Jyoti Madhusoodanan

Portland

Science Writer and Journalist at Freelance

Science journalist, UCSC SciCom '14. Words @NatureNews @undarkmag @NYTParenting @ScienceMagazine etc. Fall 2020 fellow @KSJatMIT, 2023 @APFFoundation fellow.

Featured in: Favicon

uol.com.br Favicon

cnn.com

theguardian.com Favicon

nytimes.com Favicon

estadao.com.br Favicon

nature.com Favicon

clarin.com Favicon

npr.org

pbs.org

plos.org + 102 more

Articles

What journalists should know about lab-developed tests

1 month ago | healthjournalism.org | Jyoti Madhusoodanan

Lab-developed tests (LDTs) are diagnostic tools widely used across health care to test blood, tissue or other samples for infectious diseases, genetic markers, or other biomarkers of many conditions. Unlike tests manufactured and marketed commercially, LDTs are designed and used within a single lab that meets certain stringent standards.
Beyond Bias - The Narrative Matters

1 month ago | thenarrativematters.com | Jyoti Madhusoodanan

This story delves into the harmful effects of bias and stereotypes, and offers insights on how to promote inclusivity in our communities. Articulated Insight â âNews, Race and Culture in the Information AgeâIn a now-classic series of experiments, researchers teased out the deep-rooted nature of human bias simply by distributing red shirts and blue shirts to groups of 3- to 5-year-olds at a day care center.
Vietnam War’s survivors shed light on the long-term tolls of military conflict

2 months ago | science.org | Jyoti Madhusoodanan

1.0x 00:00 7:17 1.0x Audio is AI-generated. Report an issue|Give feedback Nguyen Minh lived through war for the first 18 years of his life.
What journalists should know about race-based prescribing

Mar 10, 2025 | healthjournalism.org | Jyoti Madhusoodanan

Several prescription medications bear FDA-approved, race-specific labels that suggest certain racial or ethnic groups should receive lower doses or may be at greater risk of side effects. And guidelines to physicians, which are endorsed by professional societies, sometimes recommend prescribing certain drugs differently based on race or ethnicity. Race-based labels exist for drugs to treat heart disease, various cancers, epilepsy, tuberculosis and other diseases.
As Adults Age With MS, Should They Shed Their Meds?

Mar 3, 2025 | undark.org | Jyoti Madhusoodanan

In June 2021, 63-year-old Lisa Daurio was making the two-hour drive from her hometown of Pueblo, Colorado, to a doctor’s appointment in Denver when she settled on a life-changing decision: She would tell her doctor she was ready to stop taking her weekly injections to treat her multiple sclerosis. Daurio was not cured, but her condition had remained stable for more than a decade. As she got older, her doctor had periodically asked if she wanted to consider halting her medication.
4 angles to consider when covering the far-reaching effects of the NIH pause

Jan 28, 2025 | healthjournalism.org | Jyoti Madhusoodanan |Katie Burke

The U.S. National Institutes of Health, like many federal agencies, has experienced unprecedented restrictions on their operations in the new administration’s first week, including a communications pause that abruptly halted meetings and workshops, a hiring freeze, and a moratorium on travel. Industries and sectors connected to the biomedical sciences are experiencing concern and disarray as NIH funding and research processes have stopped.
Be careful out there: A digital safety primer for journalists

Jan 15, 2025 | healthjournalism.org | Jyoti Madhusoodanan

More than 40 percent of journalists dealt with threats and online harassment in 2022. When policymakers turn their attention to science and health issues such as vaccination, access to abortion care, and the health dangers of climate change, journalists covering these topics must be prepared to protect themselves amidst online communities that can mirror — or amplify — harmful rhetoric.
How retail pharmacies are bringing clinical trials to the community

Jan 2, 2025 | healthjournalism.org | Lara Salahi |Jyoti Madhusoodanan

Walgreens is now conducting a COVID-19 vaccine study at 20 locations across eight states, aiming to recruit 3,600 participants as part of a partnership with the U.S. government that will allow retail pharmacies to conduct clinical trials. Traditionally, these studies happen at academic centers, which can feel distant or inaccessible for many.
How one reporter covered the removal of race from common algorithms - Editor and Publisher

Nov 14, 2024 | editorandpublisher.com | Jyoti Madhusoodanan

Posted Friday, November 15, 2024 10:30 am In 2020, an NEJM publication highlighted the widespread misuse of race as a proxy for discrimination and genetic ancestry in medical algorithms.
How one reporter covered the removal of race from common algorithms

Nov 14, 2024 | healthjournalism.org | Jyoti Madhusoodanan

In 2020, an NEJM publication highlighted the widespread misuse of race as a proxy for discrimination and genetic ancestry in medical algorithms. That publication and growing social awareness of the harms of racism re-invigorated long-simmering efforts to fix biases caused by the misuse of race.